Neuroprotective agents target molecular mechanisms of disease in ALS
Highlights•Comparing agents used in ALS animal models by onset, survival and muscle
damage.•Agents are organized by individual mechanisms and effects summarized.•Analysis …
damage.•Agents are organized by individual mechanisms and effects summarized.•Analysis …
Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …
Amyotrophic lateral sclerosis: current therapeutic perspectives
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by
progressive motor neuron degeneration, muscle weakness, paralysis, and ultimately death …
progressive motor neuron degeneration, muscle weakness, paralysis, and ultimately death …
Translational Therapeutic Str ategies in Amyotrophic Lateral Sclerosis
H Ryu, RJ Ferrante - Mini Reviews in Medicinal Chemistry, 2007 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is a clinically severe and fatal neurodegenerative
disease characterized by a loss of both upper and lower motor neurons, resulting in …
disease characterized by a loss of both upper and lower motor neurons, resulting in …
New therapeutic targets for amyotrophic lateral sclerosis
M Kuzma-Kozakiewicz, H Kwiecinski - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Amyotrophic lateral sclerosis (ALS) is one of the most devastating neurological
disorders, affecting approximately half a million people worldwide. Currently there is no cure …
disorders, affecting approximately half a million people worldwide. Currently there is no cure …
Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future
D Harikrishnareddy, S Misra, S Upadhyay… - Reviews in the …, 2015 - degruyter.com
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease that rapidly
progresses from mild motor symptoms to severe motor paralysis and premature death. There …
progresses from mild motor symptoms to severe motor paralysis and premature death. There …
Prospects for the pharmacotherapy of amyotrophic lateral sclerosis: old strategies and new paradigms for the third millennium
BW Festoff, Z Suo, BA Citron - CNS drugs, 2003 - Springer
Biomedical researchers interested in amyotrophic lateral sclerosis (ALS) must invoke newly
developing technologies if we are to discover pharmaceutical treatments that will help a …
developing technologies if we are to discover pharmaceutical treatments that will help a …
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Amyotrophic lateral sclerosis (ALS) is a devastating disease caused by degeneration of
motor neurons. As with all major neurodegenerative disorders, development of disease …
motor neurons. As with all major neurodegenerative disorders, development of disease …
Novel therapeutic targets for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is an untreatable and fatal neurodegenerative disease
that is identified by the loss of motor neurons in the spinal cord, brain stem, and motor cortex …
that is identified by the loss of motor neurons in the spinal cord, brain stem, and motor cortex …
Treatment of amyotrophic lateral sclerosis: lessons learned from many failures
PH Özdinler, RB Silverman - ACS Medicinal Chemistry Letters, 2014 - ACS Publications
Amyotrophic lateral sclerosis (ALS) is one of the most complex neurodegenerative diseases,
involving both cortical and spinal components of motor neuron circuitry and non-neuronal …
involving both cortical and spinal components of motor neuron circuitry and non-neuronal …